slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
114.300 KRW | +0,62% |
|
-0,09% | -8,92% |
Vakgebied
Aantal werknemers: 2 045
Verkoop per activiteit
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Manufacturing and Sales of Pharmaceuticals, Etc.
88,6
%
| 1 484 485 | 86,7 % | 1 440 879 | 88,6 % | -2,94% |
Diagnosis and Analysis of Samples, Etc.
13,1
%
| 262 178 | 15,3 % | 213 763 | 13,1 % | -18,47% |
Consolidation
-2,9
%
| -57 445 | -3,4 % | -46 494 | -2,9 % | -19,06% |
Other
1,1
%
| 22 095 | 1,3 % | 18 496 | 1,1 % | -16,29% |
Verkoop per regio
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
South Korea
86,1
%
| 1 462 048 | 85,4 % | 1 400 272 | 86,1 % | -4,23% |
Overseas
16,8
%
| 306 710 | 17,9 % | 272 866 | 16,8 % | -11,03% |
Consolidation
-2,9
%
| -57 445 | -3,4 % | -46 494 | -2,9 % | -19,06% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Eun-Cheol Huh
CEO | Chief Executive Officer | 52 | 01-01-06 |
Ok-Gyu Go
CMP | Compliance Officer | - | 01-01-14 |
In-Jae Lee
BRD | Director/Board Member | 61 | - |
Byeong-Hwa Kim
BRD | Director/Board Member | 66 | - |
Young-Tae Lee
AUD | Comptroller/Controller/Auditor | 67 | - |
Pyeong-Joo Jang
PRN | Corporate Officer/Principal | 62 | - |
Il-Sup Huh
PRN | Corporate Officer/Principal | 70 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Il-Sup Huh
PRN | Corporate Officer/Principal | 70 | - |
Eun-Cheol Huh
CEO | Chief Executive Officer | 52 | 01-01-06 |
Byeong-Hwa Kim
BRD | Director/Board Member | 66 | - |
In-Jae Lee
BRD | Director/Board Member | 61 | - |
Choon-Woo Lee
BRD | Director/Board Member | 58 | - |
Yoon-Jae Choi
BRD | Director/Board Member | 69 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 11 686 538 | 5 400 193 ( 46,21 %) | 273 360 ( 2,339 %) | 46,21 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
GC CELL CORPORATION 33.28% | 5 257 712 | 33.28% | 128 732 397 $ |
8 765 704 | 41.47% | 25 925 797 $ | |
3 920 250 | 22.08% | 25 681 009 $ | |
GC BIOPHARMA CORP. 2.34% | 273 360 | 2.34% | 22 645 908 $ |
Bedrijfsgegevens
![Adres GC Biopharma Corp.(A006280)](https://cdn.zonebourse.com/static/address/6494409.png)
Sector
Verkoop per activiteit
Verkoop per regio
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Kwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-8,92% | 947 mln. | |
+55,32% | 815 mld. | |
+44,05% | 641 mld. | |
-6,75% | 352 mld. | |
+13,56% | 314 mld. | |
+10,68% | 303 mld. | |
+16,57% | 242 mld. | |
+2,04% | 224 mld. | |
+13,31% | 218 mld. | |
+8,48% | 168 mld. |
- Beurs
- Aandelen
- Koers A006280
- Onderneming GC Biopharma Corp.